Drugs that contain Vandetanib
1. Drug name - CAPRELSA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| USRE42353 | GENZYME CORP | Quinazoline derivatives and pharmaceutical compositions containing them |
Jun, 2022
(3 months ago) | |
| CN1142920C | GENZYME CORP | Quinazoline Derivatives And Pharmaceutical Composition Thereof And Preparation Method And Application Thereof |
Sep, 2017
(5 years ago) | |
| CN1231662A | GENZYME CORP | Quinazoline Derivatives And Pharmaceutical Composition Containing Quinazoline Derivative |
Sep, 2017
(5 years ago) | |
| EP929530A1 | GENZYME CORP | Quinazoline Derivatives And Pharmaceutical Compositions Containing Them |
Sep, 2017
(5 years ago) | |
| EP929530B1 | GENZYME CORP | Quinazoline Derivatives And Pharmaceutical Compositions Containing Them |
Sep, 2017
(5 years ago) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8067427 | GENZYME CORP | Pharmaceutical compositions comprising ZD6474 |
Aug, 2028
(5 years from now) | |
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 100MG | TABLET;ORAL | Prescription |
| 300MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.